MiR-126-3p was reported to suppress tumor metastasis and angiogenesis of hepatocellular carcinomas by targeting LRP6 and PIK3R2, and its restoration may be a promising strategy for HCC therapy [11]. The gene discussed is PIK3R2; the disease is hepatocellular carcinoma.